Pelitinib is a tyrosine kinase inhibitor that covalently binds to EGFR, inhibiting receptor phosphorylation and thus inhibiting signal transduction from EGFR. This induces apoptosis and thus leads to suppression of growth in tumor cell lines.
Veronese, M., et al.: Br. J. Cancer, 92, 1846 (2005), Hofheinz, R., et al.: Onkologie, 29, 563 (2006), Meyerhardt, J., et al.: J. Clin. Oncol., 24, 1892 (2006), Hanauske, A., et al.: Clin. Cancer Res., 13, 523 (2007).
Soluble in DMSO (13 mg/ml at 25° C), methanol, water (<1 mg/ml at 25° C), and ethanol (<1 mg/ml at 25° C).
Store at -20° C
~655.5° C at 760 mmHg (Predicted)
~1.3 g/cm3 (Predicted)
n20D 1.65 (Predicted)
EGFR : IC50 = 38.5 nM; proliferation of normal human keratinocytes: IC50 = 61 nM; proliferation of A431 tumor cells: IC50 = 125 nM; proliferation ofMDA-468 tumor cells: IC50 = 260 nM
pKa: 12.24 (Predicted), pKb: 8.01 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn